Explore our comprehensive portfolio that addresses the complete care continuum for many of the world’s most threatening diseases. 

Discover the stories of pioneers pushing the boundaries of what’s possible in healthcare to help improve people’s lives around the world.

Patient-centered innovation has been and always will be at the core of our company. Dive deeper into our fascinating technologies.

We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably. Learn more about our purpose, our innovation leadership, our culture, and our strategy.

  1. Home

  2. Press center
  3. Press releases
  4. Global Fund and Siemens Healthineers to accelerate adoption of artificial intelligence for tuberculosis diagnosis
Press release

Global Fund and Siemens Healthineers to accelerate adoption of artificial intelligence for tuberculosis diagnosis

Joint Press Release by Siemens Healthineers and The Global Fund

Published on October 16, 2023

Image Gallery

Pulmonologist and tuberculosis expert Dr. Erlina Burhan consults with medical staff at Persahabatan National Lung Hospital in Jakarta, Indonesia. Dr. Burhan has been leading the fight against tuberculosis in Indonesia for the last 30 years.

Pulmonologist and tuberculosis expert Dr. Erlina Burhan consults with medical staff at Persahabatan National Lung Hospital in Jakarta, Indonesia. Dr. Burhan has been leading the fight against tuberculosis in Indonesia for the last 30 years.

Download image

Download this press release

(pdf, 191.02 KB)
 

The Global Fund is a worldwide partnership to defeat HIV, TB and malaria and ensure a healthier, safer, more equitable future for all. We raise and invest more than US$4 billion a year to fight the deadliest infectious diseases, challenge the injustice which fuels them and strengthen health systems in more than 100 of the hardest hit countries. Since the beginning of the COVID-19 pandemic, we have invested an additional US$5 billion to fight the new pandemic and reinforce systems for health. We unite world leaders, communities, civil society, health workers and the private sector to find solutions that have the most impact, and we take them to scale worldwide. Since 2002, the Global Fund partnership has saved 59 million lives. Further information is available at https://www.theglobalfund.org/en/.

Siemens Healthineers 2023

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers and its regional companies are continuously developing their product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care. In fiscal 2022, which ended on September 30, 2022, Siemens Healthineers, which has approximately 69,500 employees worldwide, generated revenue of around €21.7 billion and adjusted EBIT of almost €3.7 billion. Further information is available at www.siemens-healthineers.com.